Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 2/20 | 0.83 |
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.83 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.83 |
| ▸ | PRKCG | P05129 | 1/20 | 0.83 |
| ▸ | PRKCB | P05771 | 1/20 | 0.83 |
| ▸ | PRKCA | P17252 | 1/20 | 0.83 |
| ▸ | PRKCH | P24723 | 1/20 | 0.83 |
| ▸ | PRKCI | P41743 | 1/20 | 0.83 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.83 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.83 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.83 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.83 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | GMNN | O75496 | 1/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10565337 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL15477735 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL10564175 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL2582886 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL1532761 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL2733343 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL10565746 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL10602960 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL4320248 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL2734265 | 1.00 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090505-A1 | FLUOROPYRIMIDINE PARTICLES FOR THE TREATMENT OF CANCER | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4726038-A1 | EXPRESSION-ADJUSTABLE ENGINEERED RNA MOLECULE | Rinuagene Biotechnology Co., Ltd. (CN) | 2026-04-15 | — | — | EP | claimed |
| US-20250302860-A1 | DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2025-10-02 | — | — | US | claimed |
| EP-4578465-A1 | INFECTION DETECTION SYSTEM | Paul Hartmann Aktiengesellschaft (DE) | 2025-07-02 | — | — | EP | claimed |
| WO-2025092866-A1 | MULTIVALENT INFLUENZA MRNA VACCINE | 仁景(苏州)生物科技有限公司 | 2025-05-08 | — | — | WO | claimed |
| US-20240366747-A1 | UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2024-11-07 | — | — | US | claimed |
| US-12053552-B2 | Functional wound dressing | PAUL HARTMANN AG (DE) | 2024-08-06 | — | — | US | claimed |
| EP-4370152-A1 | UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2024-05-22 | — | — | EP | claimed |
| EP-3569261-B1 | FUNCTIONAL WOUND DRESSING | HARTMANN PAUL AG (DE) | 2024-04-03 | — | — | EP | claimed |
| WO-2023288263-A1 | UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-01-19 | — | — | WO | claimed |
| CN-115515598-A | Pharmaceutical composition of niclosamide | 德克萨斯大学系统董事会 | 2022-12-23 | — | — | CN | claimed |
| US-20210361822-A1 | FUNCTIONAL WOUND DRESSING | PAUL HARTMANN AG (DE) | 2021-11-25 | — | — | US | claimed |
| US-10660854-B2 | Thermostable vaccines based on ether lipids and native viral envelope proteins | BATAVIA BIOSCIENCES INC. (US) | 2020-05-26 | — | — | US | claimed |
| EP-3569261-A1 | FUNCTIONAL WOUND DRESSING | Paul Hartmann AG (DE) | 2019-11-20 | — | — | EP | claimed |
| US-20180085313-A1 | Thermostable Vaccines Based On Ether Lipids And Native Viral Envelope Proteins | BATAVIA BIOSCIENCES INC. | 2018-03-29 | — | — | US | claimed |
| US-20120021130-A1 | METHOD FOR INHIBITING DECOMPOSITION OF METAL SULFIDE-CONTAINING MATERIAL | THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK, STONY BROOK (US) | 2012-01-26 | — | — | US | claimed |
| US-7153541-B2 | Method for inhibiting oxidation of metal sulfide-containing material | U.S. DEPARTMENT OF ENERGY | 2006-12-26 | — | — | US | claimed |
| US-20050036930-A1 | Method for inhibiting oxidation of metal sulfide-containing material | U.S. DEPARTMENT OF ENERGY | 2005-02-17 | — | — | US | claimed |
| EP-1033972-B1 | DRUG DELIVERY SYSTEM WITH TWO-STEP TARGETING | EDWARDS KATARINA (SE) | 2003-08-27 | — | — | EP | claimed |
| WO-2003047768-A1 | METHOD FOR INHIBITING OXIDATION OF METAL SULFIDE-CONTAINING MATERIAL | THE RESEARCH FOUNDATION (US) | 2003-06-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10660854-B2 | Thermostable vaccines based on ether lipids and native viral envelope proteins | MGLL, DDOST, PLTP | AKT1 3779/4885LMNA 1750/4885ALDH1A1 4772/4885 |
| US-20180085313-A1 | Thermostable Vaccines Based On Ether Lipids And Native Viral Envelope Proteins | MGLL, DDOST, PLTP | AKT1 3779/4885LMNA 1750/4885ALDH1A1 4772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.